Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Megha Poddar, an endocrinologist and obesity medicine specialist at LMC Endocrinology and Diabetes Group in Toronto, was unsurprised by the findings but pointed out that the study did not necessarily compare apples to apples. That is, patients receiving insulin tend to be sicker than those receiving GLP-1 agonists and may be at higher risk for obesity-related cancers, especially since insulin can contribute to weight gain
TBD, June 18
About Pfizer: Breakthroughs That Change Patients Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives
Luc JGY, Fowler CS, Eisenberg SB, Estrera AL, Wolf RK, Choi D, Lawton J, Martin L, Nesbitt JC, Reznik S, Nguyen TC, Vaporciyan AA, Antonoff MB
